PVH CORP. REPORTS 2025 FOURTH QUARTER REVENUE AND EARNINGS ABOVE GUIDANCE; PROVIDES 2026 OUTLOOK New York - March 31, 2026 - PVH Corp. [NYSE: PVH] today reported its 2025 fourth quarter and full year results and provided its 2026 outlook. Stefan Larsson, Chief Executive Officer, commented, "We delivered a strong fourth quarter and finish to the year, driven by the strength of our two iconic global brands,Calvin Klein andTOMMY HILFIGER, and the continued disciplined execution of our PVH+ Plan. In the fourth ...

Financial Results for Year Ended December 31, 2025 Exhibit 99.1 Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update -- Enrollment underway in FDA-authorized FINALE pivotal trial demonstrating execution toward FemBloc® U.S. approval -- ATLANTA, March 31, 2026 – Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results ...

Financial Performance - Total bookings for Q4 2025 reached $19.8 million, up from $14.3 million in Q4 2024, representing a growth of 38.6%[6] - Total revenue for Q4 2025 was $87.2 million, slightly down from $88.1 million in Q4 2024, with recurring revenue constituting 94% of total revenue[6] - Financial Health revenue for Q4 2025 was $56.2 million, compared to $55.0 million in Q4 2024, accounting for 65% of total revenue[6] - GAAP net loss for Q4 2025 was $5.5 million, compared to a net loss of $5.1 million in Q4 2024[6] - Non-GAAP net income for Q4 2025 was $11.4 million, a significant increase from $1.1 million in Q4 2024[6] - Adjusted EBITDA for Q4 2025 was $19.2 million, compared to $17.9 million in Q4 2024, reflecting a growth of 7.2%[6] - For the full year 2025, total revenue was $346.8 million, up from $342.2 million in 2024, with recurring revenue also at 94%[6] - Financial Health revenue for the full year 2025 was $221.7 million, compared to $217.4 million in 2024, representing 64% of total revenue[6] - GAAP net income for the full year 2025 was $4.4 million, a turnaround from a net loss of $20.9 million in 2024[6] - Non-GAAP net income for the full year 2025 was $38.5 million, compared to $4.6 million in 2024, indicating substantial improvement in profitability[6] Assets and Liabilities - Total assets increased to $402,528, up from $395,824, representing a growth of 0.18% year-over-year[19] - Total current liabilities rose to $57,959, compared to $56,000 in the previous year, showing a slight increase of 3.5%[19] - Cash and cash equivalents at the end of the period increased to $24,850, up from $12,324, marking a growth of 102.5%[22] - The company reported a provision for credit losses of $3,002 for the year, down from $3,669 in 2024, indicating improved credit quality[22] Bookings and Revenue Segments - The new Annual Contract Value (ACV) methodology was introduced, with total bookings (ACV) for 2025 at $70,889[30] - Financial Health segment bookings for the three months ended December 31, 2025, were $11,735, up from $8,515 in 2024, a growth of 37.5%[24] - Patient Care segment bookings for the twelve months ended December 31, 2025, were $35,201, compared to $33,214 in 2024, reflecting a growth of 5.9%[24] - The total recurring revenues for the twelve months ended December 31, 2025, were $327,153, slightly up from $323,379 in 2024[40] - The total non-recurring revenues for the twelve months ended December 31, 2025, were $19,683, compared to $18,826 in 2024, showing growth in this segment[40] Adjusted Metrics - Adjusted EBITDA for the twelve months ended December 31, 2025, was $68,669, compared to $55,899 in 2024, reflecting a year-over-year increase of 22.9%[33] - The adjusted EBITDA margin for the twelve months ended December 31, 2025, improved to 19.8%, compared to 16.3% in 2024[38] - Stock-based compensation for the three months ended December 31, 2025, was $3,562, an increase from $1,823 in the same period of 2024[38] Net Income and Loss - The net income (loss) for the twelve months ended December 31, 2025, was $4,354, compared to a net loss of $20,945 in 2024, indicating a significant turnaround[38] - Non-GAAP net income for the twelve months ended December 31, 2025, was $38,541, up from $4,631 in 2024, reflecting a strong operational performance[38] - The company reported a net loss margin of (6.3%) for the three months ended December 31, 2025, compared to (5.8%) in 2024[38] Financial Statement Revisions - The company made revisions to its previously issued financial statements for the years ended December 31, 2024, and December 31, 2023, to correct errors related to revenue recognition[41] - Total revenue for the twelve months ended December 31, 2024, was $342,205, a decrease of $441 compared to previously reported figures[45] - Financial Health segment revenue was $217,366, while Patient Care segment revenue was $124,839, reflecting adjustments of $(306) and $(135) respectively[45] - Total costs of revenue amounted to $168,920, with Financial Health costs at $116,738 and Patient Care costs at $52,182, showing an increase in Patient Care costs by $542[45] - The net loss for the period was $20,945, with a net loss per share of $(1.41) on both basic and diluted bases[45] - Adjusted EBITDA for the period was $55,899, reflecting a decrease of $671 from previous calculations[45] - Accounts receivable stood at $52,952, after adjustments of $(801)[45] - Deferred revenue increased to $13,678, up by $3,025 from prior figures[45] - Retained earnings decreased to $(16,577), reflecting a reduction of $(1,625)[45] - The company reported a loss before taxes of $(10,468), which included a provision for income taxes of $10,477[45] Operational Performance Evaluation - The company emphasizes the importance of non-GAAP financial measures for evaluating operational performance and trends[46]

Exhibit 99.1 TRUBRIDGE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS MOBILE, ALA. (March 31, 2026) – TruBridge, Inc. (NASDAQ: TBRG) ("TruBridge"), a leading provider of healthcare technology solutions for rural and community hospitals, today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter Financial 2025 Highlights All comparisons are to the quarter ended December 31, 2024, unless otherwise noted. Full Year 2025 Financial Highlights All comparisons ar ...

Financial Performance - Turn Therapeutics reported a net loss of $3.19 million for the year ended December 31, 2025, compared to a net loss of $1.77 million in 2024, representing an increase of 80.4%[6] - General and Administrative (G&A) expenses rose to $5.5 million in 2025, a significant increase of 266.7% from $1.5 million in 2024, primarily due to costs associated with the company's public listing[5] - Total liabilities increased to $7.48 million in 2025 from $2.23 million in 2024, indicating a rise of 235.4%[6] Research and Development - Research and Development (R&D) expenses for 2025 were $0.3 million, up from $0.2 million in 2024, indicating a 50% increase year-over-year[5] - The Phase 2 trial for GX-03 in moderate-to-severe atopic dermatitis is on track, with topline results expected in mid-2026[2] - The company expanded its intranasal vaccine pipeline to include an intranasal influenza candidate, leveraging its proprietary delivery technology[5] Capital and Funding - Cash and cash equivalents as of December 31, 2025, were $5.08 million, excluding the $7 million in gross proceeds from the Avenue Capital facility[5] - The company secured up to $25 million in growth capital from Avenue Capital to support its cash runway through the end of 2027[3] Business Development - Turn Therapeutics entered into a global supply, development, and license agreement with Medline, aiming to generate revenue in late 2026[5] - Total assets as of December 31, 2025, were $12.16 million, compared to $2.05 million in 2024, reflecting a substantial increase[6]

Store Operations - Torrid operates 483 stores across the U.S., Puerto Rico, and Canada, primarily located in premium malls and shopping centers[38] - The average store size is approximately 3,200 square feet, designed to enhance customer experience with comfortable fitting rooms[38] - As of January 31, 2026, Torrid employed approximately 1,530 full-time and 4,155 part-time employees, with a focus on creating a supportive work environment[42] - The distribution facility in West Jefferson, Ohio, spans 750,000 square feet and supports omni-channel capabilities for e-Commerce and retail store order fulfillment[54] - The company leases a 750,000 square foot distribution facility in West Jefferson, Ohio, with the lease expiring in 2030[199] Customer Demographics and Engagement - The typical customer is a woman aged 30 to 44, wearing sizes 10 to 30, with approximately half under 40 years old[29] - Torrid's loyalty program, Torrid Rewards, allows customers to earn one point for every dollar spent, with significant contributions from top-tier members accounting for a large share of net sales[30] - The company emphasizes inclusivity in its marketing, targeting curvy women and promoting confidence through its brand messaging[49] - The target market consists of approximately 30 to 44-year-old plus- and mid-size women, with changing stylistic preferences that could lead to inventory markdowns if not effectively managed[80] Product Strategy - The company introduces new merchandise approximately 16 times per year, maintaining a consistent flow of fresh products to engage customers[27] - Torrid employs a data-driven approach to product development, utilizing customer feedback and sales data to inform design and inventory decisions[26] - The e-Commerce platform is central to Torrid's strategy, providing a seamless shopping experience and expanding product offerings beyond in-store availability[35] - Torrid's unified commerce platform integrates e-Commerce and retail stores, enhancing customer acquisition and retention across channels[34] Financial Performance and Risks - In fiscal year 2025, no single quarter contributed more than 27% of the company's net sales, indicating reduced seasonality in sales[58] - The company is sensitive to consumer spending and general economic conditions, with potential adverse effects on financial performance during economic slowdowns or inflationary periods[76] - Recent inflationary pressures have increased the cost of energy and raw materials, which may negatively impact sales and results of operations if costs cannot be passed on to customers[78] - The company has substantial indebtedness and lease obligations, which could strain resources and impact financial flexibility[79] - The company has significant lease obligations, with all store locations, corporate headquarters, and distribution centers leased under operating leases with initial terms of up to ten years[94] Competition and Market Environment - The company faces competition from various players in the apparel industry, including specialty retailers and direct-to-consumer brands, emphasizing its unique focus on plus- and mid-size customers[59] - The company faces substantial competition in the plus- and mid-size women's apparel industry, which could adversely affect net sales and margins[83] - The growth strategy, including retail store optimization, is dependent on effective e-Commerce operations and the ability to secure desirable store locations[90] Supply Chain and Vendor Management - The company has a diversified vendor base, with no single supplier accounting for more than 10% of merchandise purchased in fiscal year 2025[53] - The company plans to continue diversifying its vendor bases by both vendor and geography, reducing exposure to factories located within China[53] - Approximately 19% of the company's products were sourced from China in fiscal year 2025, decreasing to about 11% as of March 2026, indicating a diversification strategy[123] - Disruptions in the supply chain due to trade restrictions or natural disasters could adversely affect inventory levels and operational efficiency[121] Regulatory and Compliance Issues - The current U.S. trade environment has introduced significant uncertainty, with increased tariffs impacting the cost of goods sold and gross margins[65] - The company is actively monitoring the tariff environment and taking steps to mitigate the impact of higher duties on its business[65] - The company is subject to evolving governmental regulations aimed at reducing greenhouse gas emissions, which may lead to increased operational costs[116] - Compliance with privacy and data protection laws is becoming increasingly complex, potentially leading to higher operational costs and legal risks[130] Cybersecurity and Operational Risks - The company is vulnerable to cybersecurity risks, and breaches could lead to financial losses and reputational damage[106] - The company recognizes the critical importance of cybersecurity and has implemented multiple layers of processes, technologies, and controls to manage risks[188] - The Board oversees the overall risk assessment process, with cybersecurity remaining a top priority[196] - The company has a written incident response plan to address cybersecurity events, outlining steps for coordination among various corporate functions[192] Financial Obligations and Shareholder Matters - As of January 31, 2026, the outstanding indebtedness under the Amended Term Loan Credit Agreement is $272.4 million, net of unamortized original issue discount and debt financing costs[158] - The company has never declared nor paid any cash dividends, and future dividend payments will depend on various factors including financial condition and contractual restrictions[176] - The company may issue securities in the future to raise capital, which could lead to dilution of existing stockholders[172] - The concentration of ownership by Sycamore Partners may conflict with the interests of other stockholders and could impede favorable corporate transactions[166]

Financial Performance - In 2025, the company reported a revenue increase of 36.5% compared to 2024, while the cost of revenue increased by 29.6%, resulting in a gross margin expansion of 2.1%[311]. - The operating loss increased by 12% to approximately $2.8 million in 2025 from about $2.5 million in 2024, primarily due to a $320K impairment of intangible assets and a $290K increase in amortization of intangibles[312]. - The company reported a net loss of $2,540,368 for the year ended December 31, 2025, compared to a net loss of $1,773,942 for 2024, reflecting an increase in non-cash expenses[338]. - Total revenue increased by $2,868,141, or 36%, for the year ended December 31, 2025, driven by acquisitions and increased digital product sales[339]. - B2B revenue increased by $2,688,302, or 62%, during the year ended December 31, 2025, primarily due to the Eastern Standard acquisition[350]. - B2C revenue increased by $179,839, or 5%, during the year ended December 31, 2025, mainly from digital product sales in the Proofread Anywhere subsidiary[353]. - Total cost of revenue increased by $982,820, or 30%, due to recent acquisitions and increased service costs[341]. - General and administrative expenses rose by $1,748,926, or 31%, during the year ended December 31, 2025, primarily due to higher advertising and contractor costs[342]. - The company recognized total impairment charges of approximately $440,000 for the year ended December 31, 2025, compared to $121,000 for 2024[346]. Cash Flow and Financing - The company ended 2025 with $2.17 million in cash, up from $0.47 million at the end of 2024, and utilized approximately $500K for regular business operations post-year-end[314]. - The company raised approximately $1,700,000 from private offerings of Series A preferred stock and $1,000,000 from common stock offerings through December 31, 2025[355]. - The company entered into a securities purchase agreement to sell $6,000,000 in Senior Secured Convertible Notes, maturing on November 17, 2027[356]. - As of December 31, 2025, the company received $2,322,500 in cash proceeds and $2,447,500 in digital assets from the Senior Secured Notes[357]. - Cash used in investing activities was $2,480,759 for the year ended December 31, 2025, primarily related to investments in digital assets, compared to cash provided of $451,000 in 2024[361]. - Cash flows from financing activities increased significantly to $5,094,351 in 2025 from $326,336 in 2024, indicating improved financing conditions[362]. - The company received $4,770,000 from convertible notes payable and $993,356 from common stock units sales during 2025, highlighting successful capital raising efforts[363]. Digital Assets and Investments - The company acquired approximately $2.4 million in digital assets, including Bitcoin, Ether, and Solana, during Q4 2025, with a total fair value of approximately $2.3 million as of December 31, 2025[308]. - The company holds digital assets including Bitcoin, Ether, and Solana, with fair value changes recognized in income, reflecting the company's engagement in cryptocurrency markets[372]. - The company utilizes a third-party asset manager for staking ETH and SOL, retaining these assets on its balance sheet measured at fair value[375]. Future Plans and Strategy - The company plans to pursue growth through acquisitions in 2026, having reviewed several promising opportunities in its pipeline[332]. - The company aims to create a unified "AgencyCo" structure to enhance alignment across its agencies, adapting to changes brought by AI in the industry[317]. - The company anticipates balancing the need to reinvent parts of its agency while ensuring continued reliable cash flow across its portfolio in 2026[319]. Non-GAAP Measures and Financial Metrics - The company presents EBITDA and EBITDA As Defined as non-GAAP financial measures to evaluate operating performance and liquidity, although these measures have limitations[384]. - EBITDA As Defined for 2025 was $151,207, a significant improvement from $(587,651) in 2024, attributed to the acquisition of Eastern Standard[313]. - EBITDA for the year ended December 31, 2025, was $(823,408), while for the year ended December 31, 2024, it was $(765,538)[391]. - Depreciation and amortization expense increased to $1,201,161 in 2025 from $906,737 in 2024[391]. - Interest expense, net, rose to $498,409 in 2025 from $101,667 in 2024[391]. - Impairment losses were reported at $733,962 for 2025, significantly higher than $121,000 in 2024[391]. - Stock-based compensation increased to $240,653 in 2025 from $56,887 in 2024[391]. - The company did not provide quantitative and qualitative disclosures about market risk, indicating a focus on internal financial metrics[392].

Operations and Production - The Eagle Springs Refinery has been operational since September 30, 2022, and is producing diesel, vacuum gas oil (VGO), naphtha, and liquid paving asphalt from crude oil suppliers in the Uintah basin [20]. - The Eagle Springs refinery experienced a shutdown during Q4 2025 for boiler repairs, negatively impacting financial results for Q3 and Q4 2025, with expectations to resume operations by the end of Q2 2026 [24]. - The Eagle Springs Refinery has a nameplate production capacity of approximately 80,000 barrels per month, with an anticipated operational output of around 45,000 barrels per month in 2026 [66]. - The PR Spring Facility is expected to produce asphalt paving aggregate from remediated asphalt shingles and mined bitumen sands [70]. - The company aims to increase production output, driven by nearby refinery shutdowns that reduce diesel supply and increase margins [89]. Financial Condition and Risks - The company has experienced recurring losses from operations, raising substantial doubt regarding its ability to continue as a going concern, and has outstanding debt that is past due [13]. - The company reported operational losses of $9,248,500 and $7,523,186 for the years ended December 31, 2025, and 2024, respectively, raising substantial doubt about its ability to continue as a going concern [113]. - As of the date of the report, the company has approximately $7,618,831 in outstanding debt that is currently past due, with reduced payments being made to lenders [115]. - The company anticipates an increase in operating expenses in the near future, with no assurance of profitability soon [118]. - The company is exploring partnerships to optimize supply costs for crude oil and petroleum inputs, which are critical for pricing products [77]. - The company faces significant environmental liabilities due to stringent regulations, which could lead to substantial costs exceeding current expectations [174]. - The company may incur substantial decommissioning costs for abandoning and reclaiming oil sands facilities, which could divert resources from other projects [164]. Technology and Innovation - The proprietary ECOSolv technology has demonstrated oil separation rates of up to 95% in bench testing, utilizing a closed-loop distillation and evaporation circuit [21]. - The ECOSolv process has demonstrated a hydrocarbon recovery factor of up to 95% from waste asphalt shingles, with less than 1% solvent remaining in the final product [61]. - The PR Spring Facility has seen an investment of approximately $6.3 million for retrofitting to utilize the ECOSolv process for recycling waste asphalt shingles into crude oil [59]. - The viability of the company's ECOSolv technology for recycling waste asphalt shingles is uncertain, and failure to perform as expected could jeopardize the business plan [147]. Market and Industry Trends - The U.S. crude oil production reached an estimated 13.6 million barrels per day in 2025, representing the highest annual output in U.S. history, with projections to remain near record levels in 2026 [31]. - The U.S. refining capacity supports high levels of refined product output, with strong refinery utilization rates, particularly during peak driving seasons [53]. - The U.S. residential and commercial roofing materials market is projected to grow at a compound annual growth rate of 4.5%, reaching an estimated size of $16 billion by 2024 [36]. - The asphalt paving market is driven by infrastructure development, with significant federal investments of $110 billion allocated for roads and bridges under the bipartisan infrastructure package [48]. - The use of reclaimed asphalt pavement (RAP) has increased by 75.2% since 2009, reducing the need for approximately 26.9 million barrels of asphalt binder [37]. Customer and Supplier Relationships - The company has a limited operating history and depends on several significant customers and suppliers, which poses risks to its financial condition and results of operations [13]. - For the year ended December 31, 2025, three customers accounted for approximately 33%, 31%, and 24% of total net sales, indicating a concentration risk [82]. - Three significant customers accounted for approximately 31%, 33%, and 24% of total net sales for the year ended December 31, 2025, indicating a reliance on a limited customer base [119]. - The company relies on a limited number of suppliers for crude oil, with one vendor accounting for 17% of its supply for the year ended December 31, 2025 [122]. - The company has identified tipping fees for waste asphalt shingles ranging from $45 to $150 per ton, with processing costs around $25 per ton [86]. Regulatory and Compliance Issues - The company is subject to various U.S. government regulations, including those from the EPA and OSHA, impacting operational compliance [102]. - The company is subject to stringent environmental regulations, which may impose substantial costs and liabilities on its operations [130]. - The company has entered into financing arrangements with covenants that could limit its ability to engage in certain transactions, potentially affecting its operational flexibility [125]. - The company received a notice of noncompliance with Nasdaq's minimum bid price requirement, risking delisting if compliance is not regained by March 23, 2026 [181]. Stock and Investment Considerations - A reverse stock split of one-for-eight (1-for-8) was effective on March 15, 2026, to comply with Nasdaq listing requirements [25]. - The market price of the company's common stock is expected to be highly volatile, potentially leading to significant investment losses for shareholders [188]. - The company does not anticipate paying any cash dividends in the foreseeable future, requiring investors to rely on stock price appreciation for returns [194]. - Future issuances of common stock or convertible securities may dilute existing shareholders' holdings and negatively impact stock price [196]. - The trading market for the company's common stock may be less active and liquid, making it difficult for shareholders to sell their shares at favorable prices [191]. - The company is classified as an emerging growth company, allowing it to take advantage of certain reporting exemptions that may result in less information available to investors [201]. Economic and Market Risks - The overall economic decline and factors such as recessionary conditions may adversely affect consumer demand for the company's products, potentially harming its financial condition and results of operations [133]. - The Consumer Price Index increased by 2.4% from January 2025 to January 2026, indicating rising inflation that could negatively impact the company's operating expenses, particularly in labor and fuel costs [136]. - The company is exposed to rising inflation rates and trade disputes that could further increase operational costs and affect cash flow [135]. - Oil prices are historically volatile, significantly impacting cash flows and capital expenditures [160]. - The U.S. Energy Information Administration projects a 5% decline in domestic motor gasoline consumption by 2026 compared to 2019 levels, driven by efficiency improvements and EV market penetration [171]. Operational Challenges - The company is currently addressing material weaknesses in its internal control over financial reporting, which, if not remediated, could lead to significant financial misstatements and loss of investor confidence [139]. - The company faces risks related to its asphalt shingle recycling operations, including price fluctuations and regulatory challenges that could impact profitability [145]. - The company does not have proven oil reserves in its bitumen deposit, which poses a risk to its planned oil sands operations and could adversely affect operating results [159]. - The company lacks supply agreements for waste asphalt shingles, which are critical for its recycling operations, potentially impacting business continuity [158]. - The company’s operations are subject to various risks, including equipment failure and cybersecurity threats, which could adversely affect business performance [168].

Financial Performance - BrainStorm reported a net loss of approximately $10.3 million for the year ended December 31, 2025, a decrease from a net loss of approximately $11.6 million in 2024, representing a 11.3% improvement [8]. - General and administrative expenses decreased to approximately $5.8 million in 2025 from $7.0 million in 2024, reflecting a 17.1% decrease [8]. - The total liabilities as of December 31, 2025, were approximately $11.0 million, an increase from $9.6 million in 2024, indicating a 14.6% rise in liabilities [14]. Research and Development - Research and development expenditures for 2025 were $4.2 million, down from $4.7 million in 2024, indicating a 10.6% reduction in R&D spending [8]. - The Phase 3b ENDURANCE study of NurOwn is expected to enroll approximately 200 participants and is designed as a two-part trial to assess long-term safety and efficacy [3]. - The primary efficacy endpoint for the Phase 3b trial will be the change from baseline to Week 24 on the ALSFRS-R scale [3]. Cash and Financing - As of December 31, 2025, cash, cash equivalents, and restricted cash totaled approximately $0.3 million, with an additional $2 million secured in early 2026 through strategic financing [8][5]. - BrainStorm's stock has experienced a significant re-rating following the $2 million financing, which is expected to support operational activities and the Phase 3b trial [2]. Clinical Outcomes - In the Expanded Access Program, 50% of patients (5 out of 10) remained alive, with an estimated mean survival of approximately 84 months, significantly exceeding the historical 5-year survival rate of ~20% [4]. Regulatory Actions - The company has filed a Citizen Petition with the FDA, requesting a renewed regulatory review of the data supporting NurOwn, highlighting ongoing interest in the therapy's potential [3].

Financial Performance - The net loss from continuing operations for the year ended December 31, 2025, was $3,595,000, a decrease of $724,000, or 17%, compared to the previous year [286]. - Total net loss for the year ended December 31, 2025, was $4,156,000, a decrease of $1,191,000, or 22%, compared to $5,347,000 for the year ended December 31, 2024 [289]. - The accumulated deficit as of December 31, 2025, was $38,557,000, indicating ongoing financial challenges and reliance on external financing [307]. - The company expects to incur losses for the foreseeable future and has substantial doubt about its ability to continue as a going concern [309]. Expenses - Research and development expenses for the year ended December 31, 2025, were $179,000, compared to $0 for the year ended December 31, 2024, reflecting increased activities following the acquisition of MitoCareX [280]. - General and administrative expenses increased by $1,826,000, or 56%, to $5,109,000 for the year ended December 31, 2025, primarily due to higher share-based compensation and professional services [281]. - Financing expenses, net for the year ended December 31, 2025, were $1,545,000, an increase of $1,293,000, or 513%, compared to the previous year [284]. Cash Flow - As of December 31, 2025, the company had cash and cash equivalents of $3,832,000, an increase from $1,923,000 as of December 31, 2024 [295]. - The company reported a net cash used in operating activities of $3,808,000 for 2025, compared to $3,419,000 for 2024, reflecting an increase in cash outflows [296]. - Net cash used in investing activities rose to $3,233,000 in 2025 from $1,889,000 in 2024, primarily due to investments in renewable energy projects and the acquisition of MitoCareX [298]. - The company generated net cash provided by financing activities of $8,856,000 in 2025, up from $3,047,000 in 2024, largely due to proceeds from standby equity purchase agreements [299]. Shareholder Information - The weighted average number of shares of common stock outstanding (basic) increased to 1,132,707 for the year ended December 31, 2025, compared to 187,215 for the previous year [279]. Strategic Agreements and Operations - The company entered into a Services Agreement with Voice Assist, which includes deferred cash consideration of up to $1,000,000 and ongoing royalty consideration based on gross profits from new projects [268]. - The company completed the sale of its NTWO OFF Ltd. operations in April 2025, impacting the financial results for the year [263]. - The company classified its Save Foods operations as held for sale and discontinued operations during 2025, affecting the overall financial performance [263]. Future Financing - Existing capital resources are projected to support operations through the first quarter of 2027, but additional capital may be needed for growth initiatives [308]. - The company entered into a purchase agreement with an investor for up to $20 million in common stock over 36 months, with shares priced at 94% of the lowest VWAP [301]. - A facility agreement was established with L.I.A. Pure Capital for a credit facility of up to EUR 6,000,000, including a five-year warrant for shares [304]. - The company raised approximately $1,500,000 in a private placement, issuing 6,250,000 units at a price of $0.24 per unit [305].